ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 105 filers reported holding ENDOLOGIX INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $330,000 | -27.3% | 67,825 | +8.2% | 0.00% | -25.0% |
Q1 2017 | $454,000 | +8.1% | 62,685 | -14.6% | 0.00% | 0.0% |
Q4 2016 | $420,000 | -58.0% | 73,390 | -6.0% | 0.00% | -55.6% |
Q3 2016 | $999,000 | +3.7% | 78,080 | +1.1% | 0.01% | 0.0% |
Q2 2016 | $963,000 | +45.5% | 77,265 | -2.4% | 0.01% | +50.0% |
Q1 2016 | $662,000 | – | 79,185 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Capital Management, LLC | 4,050,000 | $62,127,000 | 7.14% |
Essex Woodlands Management, Inc. | 1,257,468 | $24,875,000 | 4.49% |
First Light Asset Management, LLC | 304,602 | $4,673,000 | 2.20% |
ArrowMark Colorado Holdings LLC | 3,464,775 | $53,150,000 | 1.30% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,449,897 | $37,581,000 | 1.25% |
Iguana Healthcare Management, LLC | 200,000 | $3,068,000 | 0.97% |
WASHINGTON CAPITAL MANAGEMENT, INC | 82,316 | $1,262,000 | 0.71% |
PALISADE CAPITAL MANAGEMENT, LP | 1,651,798 | $25,339,000 | 0.64% |
PERKINS CAPITAL MANAGEMENT INC | 34,200 | $525,000 | 0.46% |
CADIAN CAPITAL MANAGEMENT, LP | 967,443 | $14,841,000 | 0.44% |